Profile of Surgeons Who Treat Inflammatory Bowel Diseases in Brazil

 

 Permissions and Reprints

Abstract

Objective To describe the profile of surgeons who treat patients with inflammatory bowel disease as well as the characteristics of inflammatory bowel disease care, unmet demands, and difficulties.

Methods The research participants answered a Google Forms questionnaire.

Results Of the 99 surgeons who participated in the survey, 84.5% were coloproctologists, 40% were from the southeastern region of Brazil, and 77.7% were male and had been working for more than 19 years. Regarding the healthcare sector, 63.6% of surgeons worked in both public and private clinics, and most clinically cared for up to 50 patients with inflammatory bowel disease and operated on up to 5 cases per year.

Conclusion This is the first national study that aimed to identify the profile of surgeons working with inflammatory bowel disease in Brazil. The vast majority are experienced male coloproctologists, located in the southern and southeastern regions, who perform clinical and surgical treatment of these pathologies, with major surgeries being performed in large centers by a small number of surgeons.

Ethical Approval

The study was approved by the Ethics Committee of the Brazilian Crohn's Disease and Colitis Organization (GEDIIB) under protocol number PCE0145-PO2021. All procedures were conducted in accordance with the ethical standards of Resolution 466/2012 of the Brazilian Ministry of Health's National Health Council and the Declaration of Helsinki.

Informed Consent

All participants provided written informed consent prior to inclusion in the study.

This work was conducted at the Brazilian Crohn's Disease and Colitis Organization (GEDIIB).

Publication History

Received: 31 October 2023

Accepted: 07 February 2024

Article published online:
11 March 2024

© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

• References

• 1 Vilela EG, Rocha HC, Moraes AC. et al. Inflammatory bowel disease care in Brazil: how it is performed, obstacles and demands from the physicians' perspective. Arq Gastroenterol 2020; 57 (04) 416-427 DOI: 10.1590/S0004-2803.202000000-77.
  CrossrefPubMedGoogle Scholar
• 2 Kotze PG, DamiÃo AOMC. Research in inflammatory bowel disease in Brazil: a step forward towards patient care. Arq Gastroenterol 2020; 57 (03) 225-226 DOI: 10.1590/S0004-2803.202000000-43.
  CrossrefPubMedGoogle Scholar
• 3 Feuerstein JD, Isaacs KL, Schneider Y, Siddique SM, Falck-Ytter Y, Singh S. AGA Institute Clinical Guidelines Committee. AGA Clinical Practice Guidelines on the Management of Moderate to Severe Ulcerative Colitis. Gastroenterology 2020; 158 (05) 1450-1461 DOI: 10.1053/j.gastro.2020.01.006.
  CrossrefPubMedGoogle Scholar
• 4 Dassopoulos T, Cohen RD, Scherl EJ, Schwartz RM, Kosinski L, Regueiro MD. Ulcerative Colitis Care Pathway. Gastroenterology 2015; 149 (01) 238-245 DOI: 10.1053/j.gastro.2015.05.036.
  CrossrefPubMedGoogle Scholar
• 5 Law CC, Sasidharan S, Rodrigues R. et al. Impact of Specialized Inpatient IBD Care on Outcomes of IBD Hospitalizations: A Cohort Study. Inflamm Bowel Dis 2016; 22 (09) 2149-2157 DOI: 10.1097/MIB.0000000000000870.
  CrossrefPubMedGoogle Scholar
• 6 Hartford LB, Allen LJ, Lennox H, Jairath V, Van Koughnett JAM. The Impact of Multidisciplinary Conferences on Treatment Plans for Patients With Inflammatory Bowel Disease in a Tertiary Canadian Centre. J Can Assoc Gastroenterol 2021; 4 (06) 284-289 DOI: 10.1093/jcag/gwab004.
  CrossrefPubMedGoogle Scholar
• 7 Zaltman C, Parra RS, Sassaki LY. et al. Real-world disease activity and sociodemographic, clinical and treatment characteristics of moderate-to-severe inflammatory bowel disease in Brazil. World J Gastroenterol 2021; 27 (02) 208-223 DOI: 10.3748/wjg.v27.i2.208.
  CrossrefPubMedGoogle Scholar
• 8 Scheffer M, Cassenote A, Guerra A. et al. Demografia Médica no Brasil 2020. São Paulo: Faculdade de Medicina da USP, Conselho Federal de Medicina; 2020
  Google Scholar
• 9 Spinelli A, Carvello M, Adamina M. et al. Patients' perceptions of surgery for inflammatory bowel disease. Colorectal Dis 2021; 23 (10) 2690-2698 DOI: 10.1111/codi.15813.
  CrossrefPubMedGoogle Scholar
• 10 Wewer MD, Zhao M, Nordholm-Carstensen A, Weimers P, Seidelin JB, Burisch J. The Incidence and Disease Course of Perianal Crohn's Disease: A Danish Nationwide Cohort Study, 1997-2015. J Crohn's Colitis 2021; 15 (01) 5-13 DOI: 10.1093/ecco-jcc/jjaa118.
  CrossrefPubMedGoogle Scholar
• 11 Adamina M, Bonovas S, Raine T. et al. ECCO Guidelines on Therapeutics in Crohn's Disease: Surgical Treatment. J Crohn's Colitis 2020; 14 (02) 155-168 DOI: 10.1093/ecco-jcc/jjz187.
  CrossrefPubMedGoogle Scholar
• 12 Chan WPW, Mourad F, Leong RW. Crohn's disease associated strictures. J Gastroenterol Hepatol 2018; 33 (05) 998-1008 DOI: 10.1111/jgh.14119.
  CrossrefPubMedGoogle Scholar
• 13 Aniwan S, Park SH, Loftus Jr EV. Epidemiology, Natural History, and Risk Stratification of Crohn's Disease. Gastroenterol Clin North Am 2017; 46 (03) 463-480 DOI: 10.1016/j.gtc.2017.05.003.
  CrossrefPubMedGoogle Scholar
• 14 Lightner AL, Vogel JD, Carmichael JC. et al. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Surgical Management of Crohn's Disease. Dis Colon Rectum 2020; 63 (08) 1028-1052 DOI: 10.1097/DCR.0000000000001716.
  CrossrefPubMedGoogle Scholar
• 15 Baelum JK, Qvist N, Ellebaek MB. Ileorectal anastomosis in patients with Crohn's disease. Postoperative complications and functional outcome-a systematic review. Colorectal Dis 2021; 23 (10) 2501-2514 DOI: 10.1111/codi.15839.
  CrossrefPubMedGoogle Scholar
• 16 Fornaro R, Casaccia M, Caristo G. et al. Elective surgery for ulcerative colitis, ileo-rectal anastomosis or restorative proctocolectomy An Update. Ann Ital Chir 2019; 90: 565-573
  PubMedGoogle Scholar
• 17 de Buck van Overstraeten A, Brar MS, Khorasani S, Dossa F, Myrelid P. Ileorectal Anastomosis Versus IPAA for the Surgical Treatment of Ulcerative Colitis: A Markov Decision Analysis. Dis Colon Rectum 2020; 63 (09) 1276-1284 DOI: 10.1097/DCR.0000000000001686.
  CrossrefPubMedGoogle Scholar
• 18 Holubar SD, Lightner AL, Poylin V. et al; Prepared on behalf of the Clinical Practice Guidelines Committee of the American Society of Colon and Rectal Surgeons. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Surgical Management of Ulcerative Colitis. Dis Colon Rectum 2021; 64 (07) 783-804 DOI: 10.1097/DCR.0000000000002037.
  CrossrefPubMedGoogle Scholar
• 19 Zisman TL, Bronner MP, Rulyak S. et al. Prospective study of the progression of low-grade dysplasia in ulcerative colitis using current cancer surveillance guidelines. Inflamm Bowel Dis 2012; 18 (12) 2240-2246 DOI: 10.1002/ibd.22912.
  CrossrefPubMedGoogle Scholar
• 20 Worley G, Almoudaris A, Bassett P. et al. Colectomy rates for ulcerative colitis in England 2003-2016. Aliment Pharmacol Ther 2021; 53 (04) 484-498 DOI: 10.1111/apt.16202.
  CrossrefPubMedGoogle Scholar
• 21 Heriot A, Smart P. Current Status of Segmental Colectomy in Select Crohn's Disease Patients. Clin Colon Rectal Surg 2019; 32 (04) 249-254 DOI: 10.1055/s-0039-1683906.
  Article in Thieme ConnectPubMedGoogle Scholar
• 22 Khoudari G, Mansoor E, Click B. et al. Rates of Intestinal Resection and Colectomy in Inflammatory Bowel Disease Patients After Initiation of Biologics: A Cohort Study. Clin Gastroenterol Hepatol 2022; 20 (05) e974-e983 DOI: 10.1016/j.cgh.2020.10.008.
  CrossrefPubMedGoogle Scholar